Healthcare

Safe to treat dementia patients with clot-busting drugs

Stroke patients with dementia treated with intravenous thrombolysis using powerful clot-busting drugs are at no higher risk of brain haemorrhage or death than other patients receiving the same treatment, a study from Karolinska Institutet published in the journal Neurology reports.

UCL receives largest share of NHS research funding

UCL’s three biomedical research centres (BRCs) have won more than £167 million in funding from the National Institute for Health Research (NIHR) to further world-leading biomedical research conducted with partner hospitals

UCL announces £63m Africa Health Research Institute

A new interdisciplinary research institute in South Africa to fight tuberculosis (TB), HIV and related diseases has been announced on Tuesday, following a merger between two leading research institutions, with UCL as a key academic partner

How to buy more health

Harvard economist Michael Porter argues that, to improve performance, healthcare systems need to measure not what goes in, but what comes out. A movement to focus more on such ‘patient outcomes’ is gathering speed in Europe